BPC-157 vs TB-500
BPC-157 and TB-500 are two research peptides most often studied in tendon, ligament and soft-tissue repair models. BPC-157 is a synthetic 15-amino acid sequence derived from a section of human gastric juice protein; TB-500 is a synthetic fragment corresponding to the active region of thymosin beta-4. The two are frequently studied together because their reported mechanisms do not overlap. All QSC products are sold for laboratory research use only.
Side by side
| BPC-157 | TB-500 | |
|---|---|---|
| What it is | Synthetic 15-amino acid sequence derived from a section of human gastric juice protein | Synthetic peptide fragment corresponding to the active region of thymosin beta-4 (the LKKTETQ actin-binding sequence) |
| Research models | Tendon and ligament repair, gastric and intestinal mucosal protection, vascular response to injury | Soft-tissue repair, cardiac ischaemia/reperfusion studies and corneal wound-healing assays |
| Mechanism emphasis in published models | Local growth factors and angiogenesis | Cell migration and actin dynamics |
| Typical reconstitution | 2.5–5 mg/mL in sterile or bacteriostatic water, then refrigerated | 2–5 mg/mL in sterile water |
| Reported plasma half-life | ~30 min | 2–3 hr |
| CAS number | 137525-51-0 | 77591-33-4 |
| Molecular mass | 1419.5 g/mol | 4963.4 g/mol |
| Vial sizes we sell | 5mg, 10mg, 20mg | 5mg, 10mg, 20mg |
| Price (10-vial pack) | from $60.92 ($6.09 per vial) | from $113.92 ($11.39 per vial) |
| Third-party test | 99.984% HPLC, Janoshik report #238822 | No Janoshik report published yet |
| Batch COA in our library | BP-2608 | TB-2608 |
Half-life, CAS and mass are published figures for the molecules. Prices and vial sizes are read live from our catalog.
How each is used in research
BPC-157
Its half-life is short, so multi-dose-per-day protocols are common in the published work, which mostly uses local subcutaneous or intramuscular administration in rodent models.
Sizes: 5mg, 10mg, 20mg · BPC-157 and TB-500 research hub
TB-500
Its half-life is longer than BPC-157's, which supports less frequent dosing schedules in published protocols. It is the standard partner for BPC-157 in tendon and ligament repair research.
Sizes: 5mg, 10mg, 20mg · BPC-157 and TB-500 research hub
Pre-mixed blends
Questions
What is the difference between BPC-157 and TB-500?
+
BPC-157 is a 15-amino acid sequence derived from human gastric juice protein, studied in tendon, ligament, gut-lining and vascular models. TB-500 is a synthetic fragment of thymosin beta-4 (the LKKTETQ actin-binding region), studied in soft-tissue repair, cardiac and corneal models. They are different molecules with different reported mechanisms.
Are BPC-157 and TB-500 studied together?
+
Yes. They are frequently studied side by side in tendon and soft-tissue repair research because the reported mechanisms do not overlap: BPC-157 on local growth factors and angiogenesis, TB-500 on cell migration and actin dynamics. QSC also sells them pre-mixed in one vial, for example BPC-157 5 mg + TB-500 5 mg, for protocols that prefer one reconstitution step over two.
Which has the longer half-life, BPC-157 or TB-500?
+
TB-500. The reported half-life is 2–3 hr for TB-500 against ~30 min for BPC-157. These are published figures for the molecules.
What test data does QSC publish for BPC-157 and TB-500?
+
For BPC-157, an independent Janoshik Analytical report: 99.984% HPLC purity (Janoshik report #238822). For TB-500, no Janoshik report published yet. Batch certificates of analysis (HPLC purity and LC-MS mass) are listed in the COA library by batch ID.
Which vial sizes does QSC sell?
+
Every size is a pack of ten vials. BPC-157: 5mg, 10mg, 20mg. TB-500: 5mg, 10mg, 20mg.
QSC Peptidology products are sold strictly for laboratory and research use only. See also the Janoshik test reports and the other comparisons.


